Tseng Labs Inc – ‘8-K’ for 11/3/98

As of:  Tuesday, 11/3/98   ·   For:  11/3/98   ·   Accession #:  893220-98-1667   ·   File #:  0-13502

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Form 8-K for Tseng Labs, Inc.                          3     10K 
 2: EX-99.1     Press Release Dated November 3, 1998                   1      6K 

8-K   —   Form 8-K for Tseng Labs, Inc.
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
 SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 3, 1998

TSENG LABS, INC.
 (Exact Name of Registrant Specified in Charter)

Utah                       0-13502                    87-0391229      
(State or Other            (Commission File             (I.R.S. Employer        
Jurisdiction of                 Number)                Identification No.)      
Incorporation)                                                                  

18 W. Airy Street                                       
Norristown, Pennsylvania                             19401  
(Address of Principal Executive Offices)                    (Zip Code)          

Registrant's telephone number, including area code: (610) 313-9388

 (Former Name or Former Address, if Changed Since Last Report)

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.           OTHER EVENTS.                                                 

  On November 3, 1998, the Registrant consummated the transactions
contemplated by the Agreement and Plan of Reorganization with Cell Pathways,    
Inc., a Delaware corporation, dated June 23, 1998 (the "Agreement"). For more   
details regarding this transaction, please refer to the press release dated     
November 3, 1998, which has been filed as Exhibit 99.1 hereto and is            
incorporated by reference herein.                                               

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS      

(c)      Exhibits                           

Exhibit Number             Description                                          
--------------             -----------                                          
     99.1                  Press Release issued by the Registrant on November 3,
                         1998 announcing the consummation of the transaction
with Cell Pathways, Inc.  

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
 SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the    
undersigned hereunto duly authorized.                                           

                        TSENG LABS, INC.
                              (Registrant)

                              By  /s/ Mark H. Karsch
                                Mark H. Karsch
                                           Senior Vice President and
                                         Chief Financial Officer

Dated:  November 3, 1998                                                        

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		11/3/98		1		3			15-12G
		6/23/98		2					8-K
									List all Filings